Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System
NCT01446198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11816
Last updated 2012-07-03
Summary
The objective is to establish that APTIMA HPV Assay performance on the PANTHER System is comparable to performance on the TIGRIS System.
Conditions
- Human Papilloma Virus Infection
Sponsors & Collaborators
-
Gen-Probe, Incorporated
lead INDUSTRY
Principal Investigators
-
Tadd S Lazarus, M.D. · Gen-Probe, Incorporated
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit
NCT04461678 ·Status: COMPLETED ·Phase: NA
-
HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer
NCT01984359 ·Status: COMPLETED ·Phase: NA
-
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
NCT03178136 ·Status: UNKNOWN
-
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
NCT02267876 ·Status: COMPLETED
-
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT04574635 ·Status: ACTIVE_NOT_RECRUITING
-
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
NCT07186530 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study to Identify Markers in Blood and Tissue of HPV Clearance
NCT00711815 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
NCT06498661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix
NCT04333212 ·Status: COMPLETED ·Phase: NA
-
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
NCT04131413 ·Status: RECRUITING ·Phase: PHASE1
-
European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System
NCT01671462 ·Status: COMPLETED
-
HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening
NCT02116920 ·Status: UNKNOWN
-
Blood Biomarkers Based Screening for HPV-driven OPC
NCT06528353 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
NCT01944722 ·Status: COMPLETED ·Phase: NA
-
Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia
NCT02198365 ·Status: COMPLETED
-
Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women
NCT05570331 ·Status: RECRUITING
-
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
NCT01190176 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests
NCT05536843 ·Status: UNKNOWN
-
Low-Cost Molecular Cervical Cancer Screening Study
NCT01231945 ·Status: COMPLETED
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
CINtec PLUS Triage in HPV Primary Screening
NCT03721484 ·Status: UNKNOWN ·Phase: NA
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Clinical Validation of Molecular Triage in HR-HPV Positive Women
NCT05193669 ·Status: UNKNOWN
-
Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests
NCT00526370 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
NCT07281430 ·Status: RECRUITING ·Phase: NA